Magnus Brisander,Mustafa Demirbüker,Gérald Jesson,Martin Malmsten,Helene Dérand
申请号：
US15423136
公开号：
US09833442B2
申请日:
2017.02.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
